Efficacy and Safety of a Tetravalent Dengue Vaccine (TAK-003) in Children With Prior Japanese Encephalitis or Yellow Fever Vaccination.

Autor: Sirivichayakul C; Department of Tropical Pediatrics, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand., Biswal S; Takeda Vaccines, Inc., Cambridge, Massachusetts, USA., Saez-Llorens X; Pediatric Infectious Diseases, Hospital del Niño Dr José Renán Esquivel, Sistema Nacional de Investigación at SENACYT, Centro de Vacunación Internacional (Cevaxin), Panama City, Panama., López-Medina E; Centro de Estudios en Infectologia Pediátrica, Universidad del Valle and Clínica Imbanaco Grupo Quironsalud, Cali, Colombia., Borja-Tabora C; Clinical Research Division, Research Institute for Tropical Medicine, Muntinlupa, Philippines., Bravo L; Pediatrics, University of the Philippines Manila, Ermita, Philippines., Kosalaraksa P; Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand., Alera MT; Virology, Philippines- Armed Forces Research Institute of Medical Sciences Virology Research Unit, Cebu, Philippines., Reynales H; Clinical Research, Centro de Atención e Investigación Médica, Bogotá, Colombia., Rivera L; Hospital Maternidad Nuestra Senora de Altagracia, Santo Domingo, Dominican Republic., Watanaveeradej V; Department of Pediatrics, Phramongkutklao Hospital and Kasetsart University, Bangkok, Thailand., Yu D; Pediatrics, De La Salle Health Sciences Institute, Dasmariñas, Philippines., Espinoza F; National Autonomous University of Nicaragua, León, Nicaragua., Dietze R; Núcleo de Doenças Infecciosas, Centro de Ciências da Saúde, Universidade Federal do Espirito Santo, Vitória, Brazil., Fernando L; Centre for Clinical Management of Dengue and Dengue Haemorrhagic Fever, Negombo General Hospital, Negombo, Sri Lanka., Wickramasinghe VP; Paediatrics, University of Colombo, Colombo, Sri Lanka., Moreira ED Jr; Laboratory of Molecular Epidemiology and Biostatistics, Associação Obras Sociais Irmã Dulce Hospital Santo Antônio and Oswaldo Cruz Foundation, Bahia, Brazil., Fernando AD; Faculty of Medicine, University of Kelaniya, Colombo, Sri Lanka., Gunasekera D; Faculty of Medical Sciences, University of Sri Jayawardenenpura, Nugegoda, Sri Lanka., Luz K; Instituto de Medicina Tropical da Universidade Federal do Rio Grande do Norte, Natal, Brazil., Venâncio da Cunha R; Department of Infectious Diseases, Universidade Federal de Mato Grosso do Sul, Campo Grande, Brazil., Oliveira AL; Department of Infectious Diseases, Universidade Federal de Mato Grosso do Sul, Campo Grande, Brazil., Rauscher M; Takeda Pharmaceuticals International AG, Zurich, Switzerland., Fan H; Clinchoice Inc, Fort Washington, Pennsylvania., Borkowski A; Takeda Pharmaceuticals International AG, Zurich, Switzerland., Escudero I; Takeda Vaccines, Inc., Cambridge, Massachusetts, USA., Tuboi S; Takeda Distribuidora Ltda, Sao Paulo, Brazil., Lloyd E; Takeda Vaccines, Inc., Cambridge, Massachusetts, USA., Tricou V; Takeda Pharmaceuticals International AG, Zurich, Switzerland., Folschweiller N; Takeda Pharmaceuticals International AG, Zurich, Switzerland., LeFevre I; Takeda Pharmaceuticals International AG, Zurich, Switzerland., Vargas LM; Centro de Atención e Investigación Médica, Santo Domingo, Dominican Republic., Wallace D; Takeda Vaccines, Inc., Cambridge, Massachusetts, USA.

Publikováno v: The Journal of infectious diseases [J Infect Dis] 2024 Dec 16; Vol. 230 (6), pp. e1214-e1225.

Long term T cell response and safety of a tetravalent dengue vaccine in healthy children.

Autor: Mandaric S; Takeda Pharmaceuticals International AG, Zurich, Switzerland. sanja.mandaric@takeda.com., Friberg H; Walter Reed Army Institute of Research, Silver Spring, MD, USA., Saez-Llorens X; Hospital del Niño Dr. José Renán Esquivel, Panama City, Panama.; Centro de Vacunación Internacional Cevaxin, Panama City, Panama.; Sistema Nacional de Investigación SENACYT, Panama City, Panama., Borja-Tabora C; Research Institute for Tropical Medicine, Muntinlupa, Philippines., Biswal S; Takeda Vaccines, Inc., Cambridge, MA, USA., Escudero I; Takeda Vaccines, Inc., Cambridge, MA, USA., Faccin A; Takeda Pharmaceuticals International AG, Zurich, Switzerland., Gottardo R; Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland., Brose M; Takeda Pharmaceuticals International AG, Zurich, Switzerland., Roubinis N; Takeda Pharmaceuticals International AG, Zurich, Switzerland., Fladager D; Takeda Vaccines, Inc., Cambridge, MA, USA., DeAntonio R; Centro de Vacunación Internacional Cevaxin, Panama City, Panama., Dimero JAL; Research Institute for Tropical Medicine, Muntinlupa, Philippines., Montenegro N; Centro de Vacunación Internacional Cevaxin, Panama City, Panama., Folschweiller N; Takeda Pharmaceuticals International AG, Zurich, Switzerland., Currier JR; Walter Reed Army Institute of Research, Silver Spring, MD, USA., Sharma M; Takeda Vaccines, Inc., Cambridge, MA, USA., Tricou V; Takeda Pharmaceuticals International AG, Zurich, Switzerland.

Publikováno v: NPJ vaccines [NPJ Vaccines] 2024 Oct 17; Vol. 9 (1), pp. 192. Date of Electronic Publication: 2024 Oct 17.

Immunogenicity, safety, and efficacy of a tetravalent dengue vaccine in children and adolescents: an analysis by age group.

Autor: Borja-Tabora C; Research Institute For Tropical Medicine, Muntinlupa, Philippines., Fernando L; Centre for Clinical Management of Dengue & Dengue Haemorrhagic Fever, Negombo General Hospital, Negombo, Sri Lanka., Lopez Medina E; Centro de Estudios en Infectología Pediátrica CEIP, Universidad del Valle and Clínica Imbanaco Grupo Quironsalud, Cali, Colombia., Reynales H; Centro de Atención e Investigación Médica, CAIMED, Bogotá, Colombia., Rivera L; Hospital Maternidad Nuestra Senora de Altagracia, Santo Domingo, Dominican Republic., Saez-Llorens X; Hospital del Niño Dr. José Renán Esquivel, Sistema Nacional de Investigación at SENACYT, Centro de Vacunación Internacional (Cevaxin), Panama City, Panama., Sirivichayakul C; Department of Tropical Pediatrics, Faculty of Tropical Medicine, Mahidol University, Thailand., Yu D; De La Salle Medical and Health Sciences Institute, Dasmariñas, Philippines., Folschweiller N; Takeda Pharmaceuticals International AG, Zurich, Switzerland., Moss KJ; Takeda Vaccines, Inc., Cambridge, MA, USA., Rauscher M; Takeda Pharmaceuticals International AG, Zurich, Switzerland., Tricou V; Takeda Pharmaceuticals International AG, Zurich, Switzerland., Zhao Y; Takeda Vaccines, Inc., Cambridge, MA, USA., Biswal S; Takeda Vaccines, Inc., Cambridge, MA, USA.

Publikováno v: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America [Clin Infect Dis] 2024 Jul 12. Date of Electronic Publication: 2024 Jul 12.

Molecular characterization of measles viruses in Central African Republic, 2012-2016.

Autor: Dote J; Institut Pasteur de Bangui, Bangui, Central African Republic., Tricou V; Institut Pasteur de Bangui, Bangui, Central African Republic., Gnikpingo LK; Université de Bangui, Bangui, Central African Republic., Pagonendji M; Institut Pasteur de Bangui, Bangui, Central African Republic., Charpentier E; Department of Infection and Immunity, Luxembourg Institute of Health, Esch-sur-Alzette, Luxembourg., Hübschen JM; Department of Infection and Immunity, Luxembourg Institute of Health, Esch-sur-Alzette, Luxembourg., Gouandjika-Vasilache I; Institut Pasteur de Bangui, Bangui, Central African Republic.

Publikováno v: Journal of medical virology [J Med Virol] 2023 Aug; Vol. 95 (8), pp. e29003.

Long-term efficacy and safety of a tetravalent dengue vaccine (TAK-003): 4·5-year results from a phase 3, randomised, double-blind, placebo-controlled trial.

Autor: Tricou V; Takeda Pharmaceuticals International, Zurich, Switzerland. Electronic address: Vianney.Tricou@takeda.com., Yu D; Pediatrics, De La Salle Medical and Health Sciences Institute, Dasmariñas, Philippines., Reynales H; Clinical Research, Centro de Atención e Investigación Médica, CAIMED, Bogotá, Colombia., Biswal S; Takeda Vaccines, Cambridge, MA, USA., Saez-Llorens X; Pediatric Infectious Diseases, Hospital del Niño Dr. José Renán Esquivel, Sistema Nacional de Investigación at SENACYT, Centro de Vacunación Internacional (Cevaxin), Panama City, Panama., Sirivichayakul C; Department of Tropical Pediatrics, Faculty of Tropical Medicine, Mahidol University, Bangkok, Thailand., Lopez P; Centro de Estudios en Infectología Pediátrica, Universidad del Valle and Centro Medico Imbanaco, Cali, Colombia., Borja-Tabora C; Clinical Research Division, Research Institute For Tropical Medicine, Muntinlupa, Philippines., Bravo L; Pediatrics, University of the Philippines Manila, Ermita, Philippines., Kosalaraksa P; Department of Pediatrics, Faculty of Medicine, Khon Kaen University, Khon Kaen, Thailand., Vargas LM; CAIMED, Dominicana, Santo Domingo, Dominican Republic., Alera MT; Virology, Philippines-Armed Forces Research Institute of Medical Sciences Virology Research Unit, Cebu City, Philippines., Rivera L; Hospital Maternidad Nuestra Senora de Altagracia, Santo Domingo, Dominican Republic., Watanaveeradej V; Department of Pediatrics, Phramongkutklao Hospital and Faculty of Medicine, Kasetsart University, Bangkok, Thailand., Dietze R; Núcleo de Doenças Infecciosas, Centro de Ciencias da Saude-UFES, Vitória, Brazil., Fernando L; Centre for Clinical Management of Dengue & Dengue Haemorrhagic Fever, Negombo General Hospital, Negombo, Sri Lanka., Wickramasinghe VP; Paediatrics, University of Colombo, Colombo, Sri Lanka., Moreira ED Jr; Laboratory of Molecular Epidemiology and Biostatistics, Associação Obras Sociais Irmã Dulce Hospital Santo Antônio and Oswaldo Cruz Foundation, Bahia, Brazil., Fernando AD; Faculty of Medicine, University of Kelaniya, Colombo, Sri Lanka., Gunasekera D; Faculty of Medical Sciences, University of Sri Jayawardenenpura, Nugegoda, Sri Lanka., Luz K; Instituto de Medicina Tropical da Universidade Federal do Rio Grande do Norte, Natal, Brazil., Oliveira AL; Department of Infectious Diseases, Universidade Federal de Mato Grosso do Sul, Campo Grande, Brazil., Tuboi S; Takeda Pharmaceuticals, Sao Paulo, Brazil., Escudero I; Takeda Vaccines, Cambridge, MA, USA., Hutagalung Y; Takeda Vaccines, Singapore., Lloyd E; Takeda Vaccines, Cambridge, MA, USA., Rauscher M; Takeda Pharmaceuticals International, Zurich, Switzerland., Zent O; Takeda Pharmaceuticals International, Zurich, Switzerland., Folschweiller N; Takeda Pharmaceuticals International, Zurich, Switzerland., LeFevre I; Takeda Pharmaceuticals International, Zurich, Switzerland; Regulatory Affairs, GlaxoSmithKline, Zug, Switzerland., Espinoza F; National Autonomous University of Nicaragua, León, Nicaragua., Wallace D; Takeda Vaccines, Cambridge, MA, USA.

Publikováno v: The Lancet. Global health [Lancet Glob Health] 2024 Feb; Vol. 12 (2), pp. e257-e270.